Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance.

Loret N, Denys H, Tummers P, Berx G.

Cancers (Basel). 2019 Jun 17;11(6). pii: E838. doi: 10.3390/cancers11060838. Review.

2.

Meeting Report: First State-of-the-Art Meeting on Uterus Transplantation.

Tummers P, Göker M, Dahm-Kahler P, Brännström M, Tullius SG, Rogiers X, Van Laecke S, Weyers S.

Transplantation. 2019 Mar;103(3):455-458. doi: 10.1097/TP.0000000000002561. No abstract available.

PMID:
30747845
3.

Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.

Couvreur K, Naert E, De Jaeghere E, Tummers P, Makar A, De Visschere P, Van Bockstal M, Van Dorpe J, De Neve W, Denys H, Vandecasteele K.

BMC Cancer. 2018 Nov 12;18(1):1101. doi: 10.1186/s12885-018-5007-0.

4.

EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.

Vandecasteele K, Tummers P, Van Bockstal M, De Visschere P, Vercauteren T, De Gersem W, Denys H, Naert E, Makar A, De Neve W.

BMC Cancer. 2018 Sep 17;18(1):898. doi: 10.1186/s12885-018-4800-0.

5.
6.

Primary intestinal type adenocarcinoma of the female genital tract, arisen from a tubulo-villous adenoma: Case report.

van Wessel S, Van Kerrebroeck H, Van Bogaert V, Tummers P, Van den Broecke R.

Gynecol Oncol Case Rep. 2013 Jan 29;4:63-5. doi: 10.1016/j.gynor.2013.01.005. eCollection 2013.

7.

Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer: feasibility, surgical outcome, and oncologic results.

Tummers P, Makar A, Vandecasteele K, De Meerleer G, Denys H, De Visschere P, Delrue L, Villeirs G, Lambein K, den Broecke RV.

Int J Gynecol Cancer. 2013 Jun;23(5):877-83. doi: 10.1097/IGC.0b013e31828d1ec0.

PMID:
23698797
8.

Interobserver variability of the International Federation of Gynecology and Obstetrics staging in cervical cancer.

Tummers P, Gerestein K, Mens JW, Verstraelen H, van Doorn H.

Int J Gynecol Cancer. 2013 Jun;23(5):890-4. doi: 10.1097/IGC.0b013e318292da65.

PMID:
23640293
9.

Postoperative intensity-modulated arc therapy for cervical and endometrial cancer: a prospective report on toxicity.

Vandecasteele K, Tummers P, Makar A, van Eijkeren M, Delrue L, Denys H, Lambert B, Beerens AS, Van den Broecke R, Lambein K, Fonteyne V, De Meerleer G.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):408-14. doi: 10.1016/j.ijrobp.2011.12.020. Epub 2012 Feb 28.

PMID:
22377596
10.

Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.

Vandecasteele K, Delrue L, Lambert B, Makar A, Lambein K, Denys H, Tummers P, Van den Broecke R, Villeirs G, De Meerleer G.

Int J Gynecol Cancer. 2012 May;22(4):630-7. doi: 10.1097/IGC.0b013e3182428925.

PMID:
22237382
11.

Risk of spontaneous abortion in singleton and twin pregnancies after IVF/ICSI.

Tummers P, De Sutter P, Dhont M.

Hum Reprod. 2003 Aug;18(8):1720-3.

PMID:
12871890

Supplemental Content

Loading ...
Support Center